People who have a genetic mutation for hereditary non-polyposis colon cancer (HNPCC), also known as Lynch Syndrome, have a very high risk of developing colon or rectal cancer in their lifetime. Now research shows that 1 in 25 mutation carriers will also face small bowel cancer during their lives. Their lifetime risk of small bowel cancer was 4.2 percent.
Researchers in the Netherlands studied 1,500 people from 190 families who carried one of the inherited genes associated with HNPCC. They found 28 cases of small bowel cancer. The cancer was diagnosed at an average age of 52, although time of diagnosis ranged from age 23 to 69.
Given the fairly low risk, doctors do not recommend invasive and difficult enteroscopy screening for small bowel cancers in all HNPCC mutation carriers. However, as video capsule endoscopy techniques develop and become cost effective, they might provide a method of screening.
Small bowel cancer should be considered in people with HNPCC who have abdominal pain or anemia.
There was no difference in small bowel cancers between men and women or between patients with a MLH1 or MSH2 mutation. None of the patients with an MSH6 mutation in the study developed small bowel cancer.
Previous colorectal cancer or family history of small bowel cancer did not increase risk.
G L ten Kate and colleagues at the Dutch HNPCC-Registry the Leiden University Medical Centre wrote,
Approximately, one out of 25 mutation carriers will develop SBC during life. No specific risk factors were identified. The risk appeared to be too low to advise screening by means of an invasive burdensome procedure like double balloon enteroscopy. However, screening by a non-invasive procedure (videocapsule endoscopy) might be considered if future studies will show its cost effectiveness. In patients with unexplained abdominal complaints and/or unexplained iron deficiency anemia SBC should be considered.
SOURCE: ten Kate et al, GUT, Volume 56, Number 9, September 2007.


